{
  "ptid_time": "023_S_0887_2012-10-25",
  "img_path": "/data/qiuhui/data/adni/images/023_S_0887/2012-10-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 79,558 mm³, 183.4% above the reference mean. With a Z-score of 4.20 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 3,470 mm³, 51.2% below the reference mean. With a Z-score of -4.70 (0.0th percentile), this represents profound atrophy; whole brain volume measures 785,720 mm³, 19.4% below the reference mean. With a Z-score of -2.44 (0.7th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,944 mm³, 47.1% below the reference mean. With a Z-score of -2.89 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 10,372 mm³, 39.0% below the reference mean. With a Z-score of -3.55 (0.0th percentile), this represents profound atrophy; middle temporal gyrus volume measures 11,513 mm³, 39.9% below the reference mean. With a Z-score of -3.47 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 79.7 years. Gender is Female. Education: 8 years. MMSE: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.24 SUVR (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus) alongside significant whole-brain atrophy and severe ventricular enlargement. The MMSE score of 4.0 indicates severe cognitive impairment, and the presence of APOE4 and mild amyloid elevation (AV45) further supports Alzheimer's pathology.  \n\n**Diagnosis:** **Dementia** (consistent with late-stage Alzheimer's disease)  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T02:48:43.142435"
}